Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee
- 6 December 2012
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 367 (23), 2194-2203
- https://doi.org/10.1056/nejmoa1212972
Abstract
We investigated an outbreak of fungal infections of the central nervous system that occurred among patients who received epidural or paraspinal glucocorticoid injections of preservative-free methylprednisolone acetate prepared by a single compounding pharmacy. Case patients were defined as patients with fungal meningitis, posterior circulation stroke, spinal osteomyelitis, or epidural abscess that developed after epidural or paraspinal glucocorticoid injections. Clinical and procedure data were abstracted. A cohort analysis was performed. The median age of the 66 case patients was 69 years (range, 23 to 91). The median time from the last epidural glucocorticoid injection to symptom onset was 18 days (range, 0 to 56). Patients presented with meningitis alone (73%), the cauda equina syndrome or focal infection (15%), or posterior circulation stroke with or without meningitis (12%). Symptoms and signs included headache (in 73% of the patients), new or worsening back pain (in 50%), neurologic symptoms (in 48%), nausea (in 39%), and stiff neck (in 29%). The median cerebrospinal fluid white-cell count on the first lumbar puncture among patients who presented with meningitis, with or without stroke or focal infection, was 648 per cubic millimeter (range, 6 to 10,140), with 78% granulocytes (range, 0 to 97); the protein level was 114 mg per deciliter (range, 29 to 440); and the glucose concentration was 44 mg per deciliter (range, 12 to 121) (2.5 mmol per liter [range, 0.7 to 6.7]). A total of 22 patients had laboratory confirmation of Exserohilum rostratum infection (21 patients) or Aspergillus fumigatus infection (1 patient). The risk of infection increased with exposure to lot [email protected], older vials, higher doses, multiple procedures, and translaminar approach to epidural glucocorticoid injection. Voriconazole was used to treat 61 patients (92%); 35 patients (53%) were also treated with liposomal amphotericin B. Eight patients (12%) died, seven of whom had stroke. We describe an outbreak of fungal meningitis after epidural or paraspinal glucocorticoid injection with methylprednisolone from a single compounding pharmacy. Rapid recognition of illness and prompt initiation of therapy are important to prevent complications. (Funded by the Tennessee Department of Health and the Centers for Disease Control and Prevention.)This publication has 24 references indexed in Scilit:
- The Index Case for the Fungal Meningitis Outbreak in the United StatesNew England Journal of Medicine, 2012
- Safe Preparation and Administration of Intravitreal Bevacizumab InjectionsNew England Journal of Medicine, 2011
- An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Antimicrobials and the Risk of Torsades de PointesDrug Safety, 2010
- Exserohilum: an emerging human pathogenEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Epidural Abscess and Meningitis After Epidural Corticosteroid InjectionMayo Clinic Proceedings, 2004
- Cervical Epidural Abscess After Epidural Steroid InjectionSpine, 2004
- VoriconazoleDrugs, 2002
- A case of cutaneous phaeohyphomycosis caused byExserohilum rostratum, its in vitro sensitivity and review of literatureMycopathologia, 1995
- Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesisMicrobiology, 1994